US Stock MarketDetailed Quotes

ZyVersa Therapeutics (ZVSA)

Watchlist
  • 0.1850
  • -0.0148-7.41%
15min DelayClose May 15 15:02 ET
901.59KMarket Cap-0.04P/E (TTM)

ZyVersa Therapeutics (ZVSA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.99%-5.11M
65.94%-413.69K
-129.09%-1.41M
20.50%-1.52M
53.08%-1.77M
13.77%-7.52M
56.42%-1.21M
34.41%-614.14K
-369.58%-1.91M
17.71%-3.78M
Net income from continuing operations
-165.07%-24.95M
52.27%-678.57K
-724.80%-19.81M
19.99%-2.21M
20.16%-2.26M
90.42%-9.41M
89.34%-1.42M
17.27%-2.4M
96.48%-2.76M
20.24%-2.83M
Depreciation and amortization
--0
--0
--0
--0
--0
-33.34%6.93K
--0
-33.35%1.73K
0.00%2.6K
0.00%2.6K
Deferred tax
-12,726.52%-851.66K
--0
---851.66K
----
----
100.07%6.75K
99.50%-2.96K
--0
100.12%9.71K
--0
Other non cash items
17.30%240K
--0
--29.6K
--128.8K
-6.25%81.6K
-89.34%204.61K
31.13%117.57K
--0
--0
-79.14%87.04K
Change In working capital
56.87%1.52M
378.70%190.29K
-69.30%498.82K
-25.88%501.59K
126.20%330.99K
-62.70%970.05K
95.12%-68.28K
-4.32%1.62M
-77.51%676.68K
-78.97%-1.26M
-Change in prepaid assets
333.05%115.16K
168.01%221.43K
-68.99%78.91K
-51.34%128.73K
51.78%-313.91K
-125.59%-49.41K
-26.61%82.62K
-44.74%254.41K
-63.06%264.57K
40.61%-651.02K
-Change in payables and accrued expense
36.81%1.41M
79.36%-31.14K
-69.36%419.91K
-7.49%381.25K
205.49%636.51K
-59.00%1.03M
89.85%-150.9K
8.50%1.37M
-82.21%412.11K
-245.50%-603.4K
-Change in other current liabilities
--0
--0
--0
--0
--0
91.35%-8.66K
--0
--0
--0
64.30%-8.66K
-Change in other working capital
----
----
----
----
--8.39K
--97.88K
--128.14K
----
----
----
Cash from discontinued investing activities
Operating cash flow
31.99%-5.11M
65.94%-413.69K
-129.09%-1.41M
20.50%-1.52M
53.08%-1.77M
13.77%-7.52M
56.42%-1.21M
34.41%-614.14K
-369.58%-1.91M
17.71%-3.78M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-37.67%3.69M
-100.48%-12.51K
201.63%1.86M
-17.72K
-30.68%1.85M
-0.73%5.91M
-39.66%2.62M
-72.99%617.58K
0
7,807.50%2.67M
Net common stock issuance
--0
----
----
----
----
-92.52%1.35M
--0
--0
----
----
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-21.88%4.05M
--0
147.81%2.05M
--2.15M
-105.51%-147.13K
436.10%5.19M
941,860.89%1.69M
-14.40%827.98K
--0
--2.67M
Net other financing activities
41.64%-366.62K
97.01%-12.51K
---189.05K
---2.16M
--2M
74.07%-628.21K
36.07%-417.81K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-37.67%3.69M
-100.48%-12.51K
201.63%1.86M
---17.72K
-30.68%1.85M
-0.73%5.91M
-39.66%2.62M
-72.99%617.58K
--0
7,807.50%2.67M
Net cash flow
Beginning cash position
-51.21%1.53M
329.53%527.98K
-39.67%72.09K
-20.75%1.61M
-51.21%1.53M
-46.84%3.14M
-92.21%122.92K
-47.75%119.49K
59.11%2.03M
-46.84%3.14M
Current changes in cash
11.05%-1.43M
-130.27%-426.2K
13,171.97%455.89K
19.57%-1.54M
107.30%80.61K
41.88%-1.61M
-9.68%1.41M
-99.75%3.44K
-82.40%-1.91M
76.12%-1.1M
End cash Position
-93.35%101.78K
-93.35%101.78K
329.53%527.98K
-39.67%72.09K
-20.75%1.61M
-51.21%1.53M
-51.21%1.53M
-92.21%122.92K
-47.75%119.49K
59.11%2.03M
Free cash flow
31.99%-5.11M
65.94%-413.69K
-129.09%-1.41M
20.50%-1.52M
53.08%-1.77M
13.77%-7.52M
56.42%-1.21M
34.41%-614.14K
-369.58%-1.91M
17.71%-3.78M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.99%-5.11M65.94%-413.69K-129.09%-1.41M20.50%-1.52M53.08%-1.77M13.77%-7.52M56.42%-1.21M34.41%-614.14K-369.58%-1.91M17.71%-3.78M
Net income from continuing operations -165.07%-24.95M52.27%-678.57K-724.80%-19.81M19.99%-2.21M20.16%-2.26M90.42%-9.41M89.34%-1.42M17.27%-2.4M96.48%-2.76M20.24%-2.83M
Depreciation and amortization --0--0--0--0--0-33.34%6.93K--0-33.35%1.73K0.00%2.6K0.00%2.6K
Deferred tax -12,726.52%-851.66K--0---851.66K--------100.07%6.75K99.50%-2.96K--0100.12%9.71K--0
Other non cash items 17.30%240K--0--29.6K--128.8K-6.25%81.6K-89.34%204.61K31.13%117.57K--0--0-79.14%87.04K
Change In working capital 56.87%1.52M378.70%190.29K-69.30%498.82K-25.88%501.59K126.20%330.99K-62.70%970.05K95.12%-68.28K-4.32%1.62M-77.51%676.68K-78.97%-1.26M
-Change in prepaid assets 333.05%115.16K168.01%221.43K-68.99%78.91K-51.34%128.73K51.78%-313.91K-125.59%-49.41K-26.61%82.62K-44.74%254.41K-63.06%264.57K40.61%-651.02K
-Change in payables and accrued expense 36.81%1.41M79.36%-31.14K-69.36%419.91K-7.49%381.25K205.49%636.51K-59.00%1.03M89.85%-150.9K8.50%1.37M-82.21%412.11K-245.50%-603.4K
-Change in other current liabilities --0--0--0--0--091.35%-8.66K--0--0--064.30%-8.66K
-Change in other working capital ------------------8.39K--97.88K--128.14K------------
Cash from discontinued investing activities
Operating cash flow 31.99%-5.11M65.94%-413.69K-129.09%-1.41M20.50%-1.52M53.08%-1.77M13.77%-7.52M56.42%-1.21M34.41%-614.14K-369.58%-1.91M17.71%-3.78M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -37.67%3.69M-100.48%-12.51K201.63%1.86M-17.72K-30.68%1.85M-0.73%5.91M-39.66%2.62M-72.99%617.58K07,807.50%2.67M
Net common stock issuance --0-----------------92.52%1.35M--0--0--------
Net preferred stock issuance ----------------------0--0--0--------
Proceeds from stock option exercised by employees -21.88%4.05M--0147.81%2.05M--2.15M-105.51%-147.13K436.10%5.19M941,860.89%1.69M-14.40%827.98K--0--2.67M
Net other financing activities 41.64%-366.62K97.01%-12.51K---189.05K---2.16M--2M74.07%-628.21K36.07%-417.81K------------
Cash from discontinued financing activities
Financing cash flow -37.67%3.69M-100.48%-12.51K201.63%1.86M---17.72K-30.68%1.85M-0.73%5.91M-39.66%2.62M-72.99%617.58K--07,807.50%2.67M
Net cash flow
Beginning cash position -51.21%1.53M329.53%527.98K-39.67%72.09K-20.75%1.61M-51.21%1.53M-46.84%3.14M-92.21%122.92K-47.75%119.49K59.11%2.03M-46.84%3.14M
Current changes in cash 11.05%-1.43M-130.27%-426.2K13,171.97%455.89K19.57%-1.54M107.30%80.61K41.88%-1.61M-9.68%1.41M-99.75%3.44K-82.40%-1.91M76.12%-1.1M
End cash Position -93.35%101.78K-93.35%101.78K329.53%527.98K-39.67%72.09K-20.75%1.61M-51.21%1.53M-51.21%1.53M-92.21%122.92K-47.75%119.49K59.11%2.03M
Free cash flow 31.99%-5.11M65.94%-413.69K-129.09%-1.41M20.50%-1.52M53.08%-1.77M13.77%-7.52M56.42%-1.21M34.41%-614.14K-369.58%-1.91M17.71%-3.78M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More